IPO Details
Issue Date
07 Jul - 9 Jul'25
Investment/lot
₹ 297600
Price Range
236 - 248
Lot Size
1200
IPO Size
₹ 76.2 - ₹ 80.08 Cr
Schedule of Chemkart India IPO
Start date
07/07/2025
End date
09/07/2025
Allotment of bids
Refund Initiation
Listing on exchange
About Chemkart India Ltd IPO
A 100% book-built offer, the IPO of Chemakart India Ltd comprises a fresh issue and an offer for sale of up to 26,00,000 and 6,30,000 equity shares, respectively. The IPO will open on TBA and close on TBA. The credit of shares to the demat account will take place on TBA. The basis of allotment will take place on TBA and the initiation of refunds will take place on TBA.
Objectives of Chemkart India Ltd IPO
- Financing the capital expenditure towards setting up of the manufacturing facility through investment in its wholly-owned subsidiary (WOS) company, Easy Raw Materials Private Limited
- Repayment/prepayment of all or certain of its borrowings availed of by the company
- General corporate purposes
Chemkart India Ltd IPO Valuation
| Detail | Information |
|---|---|
Upper Price Band | TBA |
Fresh Issue | Up to 26,00,000 equity shares |
Offer For Sale | Up to 6,30,000 equity shares |
EPS in ₹ for FY 24 | 15.28 |
Chemkart India Ltd Share Offer and Subscription Details
| Investor Category | Shares Offered |
|---|---|
QIBs | Not more than 50% of the offer |
Non-institutional Bidders | Not less than 15% of the net offer |
Individual Investors | Not less than 35% of the net offer |
Industry Outlook
The global nutraceutical market is currently estimated at around $400 billion, blending the fields of food, pharmaceuticals, and biotechnology. India stands out as a key player, supported by its rich heritage of traditional knowledge, especially in Ayurveda, and a unique ecosystem that fosters growth in this sector. However, India's share remains under 2% globally, primarily due to a lack of defined industry classification within Indian ministries, limiting targeted sector support.
Through the Department of Commerce, India has showcased its nutraceutical strengths at global trade fairs, enhancing visibility and forging connections with international stakeholders. The collaboration between the Task Force and the Central Board of Indirect Taxes and Customs (CBIC) is working toward a unique HSN code to streamline exports and simplify customs procedures.
With these strategic initiatives, India’s nutraceutical sector is set for unprecedented growth. India aims to position itself as a global leader in nutraceuticals, combining traditional knowledge with modern science to attract global partnerships and investments.
Company Information
Chemkart India Ltd is a one stop destination for various nutritional, Health and sports supplement products. The company focuses on providing health benefits in addition to their nutritional values, reflecting its ability in catering to nutritional as well as health needs of the end customers.
The company is based in Mumbai, offering a diverse range of captivated nutritional supplements and components. It targets the Business-to-Business (B-to-B) businesses which uses its products into manufacturing of finished supplements which includes sports supplements, health supplements, vitamins, protein products etc.
Chemkart India Ltd Strengths
Diversified product portfolio
Chemkart India Ltd believes that understanding of the customer’s requirements, its product understanding capabilities, has allowed it to develop a comprehensive portfolio of a variety of nutraceutical products.
It offers products mainly across seven product categories, i.e. Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, Vitamin and many more under other health products category in different packaging sizes. It believes that its diversified product portfolio enables it to cater to a wide range of customer preferences.
In house processing and warehousing capabilities
The company is equipped with a warehouse which enables blending, grinding and packaging of ingredients all in a hygienic way. It believes that it has trained and experienced staff in terms of blending grinding and hygienic storages/ warehousing facilities.
Its own warehousing facility located at Bhiwandi, Mumbai spreads across 28,259.16 Sq Ft. comprising three floors, equipped with all the required machinery to carry out the process of blending, grinding and packing including labelling and sealing of the final ingredients in a smooth and efficient manner.
Value proposition for customers
Chemkart India Ltd is catering to the B2B segment which gives it the advantage of a widespread customer network. It seeks to build on existing relationships and also focus on bringing into its portfolio more customers.
The company believes that business is a byproduct of relationships. The company believes that a long-term customer relationship with large customers reap fruitful returns.
Risks of Chemkart India Ltd IPO
-
Risk of Supply Chain Disruption: Chemkart’s business operations rely significantly on the continuous and timely supply of products from top 5 and top 10 suppliers, Also, it doesn’t have continuing and exclusive supply agreements with them. Any interruptions or discontinuation of the same will adversely impact its overall performance and profitability.
-
Dependence on International Risks: The company sources majority of the products from international market i.e. China. Any adverse developments affecting its procurement in this region could have an adverse impact on its revenue and results of operations.
-
Geographical concentration risk: The company generates majority of the sales from domestic markets of which major portion of sales from its operations is generated from certain geographical regions especially, Maharashtra, Gujarat and New Delhi and minority portion of sales are from the international market.
Any adverse developments affecting its operations in these regions could have an adverse impact on its revenue and results of operations.
All Financial Information about Chemkart India
Particulars (in Rs. crores)
Particulars (in Rs. crores)
Peer Comparison
There are no listed companies in India that are engaged in a business similar to that of Chemkart India Ltd. Accordingly, it is not possible to provide a comparison of key performance indicators of industry with Chemkart.
Anchor Investor Bidding Date TBA
IPO Registrar and Book Running Lead Managers
- Registrar: Bigshare Services Pvt Ltd
- Book Running Lead Manager: Smart Horizon Capital Advisors Private Limited
Business Model
Established in 2020, Chemkart India Ltd offers products across mainly seven product categories, i.e. Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin. There are many more under other health products categories in different packaging sizes.
Company Growth Trajectory
For the financial year 2024, the company’s revenue from operations was ₹132.0269 crores, increasing from ₹131.3776 crores in FY 23 and ₹86.9805 crore in FY 22, growing at a CAGR of 23.20% between the financial years 2022 and 2024. Its EBITDA margin increased from 8.07% in FY 22 to 15.84% in FY 24.
Market Position
A one stop destination for various nutritional, health and sports supplement products, Chemkart India Ltd specialises in mainly amino acids. Its product assortment and customer-centric approach aims to fulfil the daily and aspirational requirements of the end customers with a focus on variety, affordability, quality and convenience.
Chemkart India Ltd Profit and Loss
| Parameter | FY 24 | FY 23 | FY 22 |
|---|---|---|---|
Total Income (in ₹ crores) | 132.8277 | 131.6862 | 87.4321 |
Profit/(Loss) Before Tax (in ₹ crores) | 19.9540 | 10.5173 | 7.3221 |
Profit/(Loss) After Tax (in ₹ crores) | 14.5182 | 7.6602 | 5.4793 |
EPS in ₹ | 15.28 | 8.06 | 6.71 |
Chemkart India Ltd Balance Sheet
| Parameter | FY 24 | FY 23 | FY 22 |
|---|---|---|---|
Profit/(Loss) Before Tax (in ₹ crores) | 19.9540 | 10.5173 | 7.3221 |
Net Cash (Used in)/Generated from Operating Activities (in ₹ crores) | (0.0234) | 0.059 | 6.3911 |
Net Cash (Used in)/Generated from Investing Activities (in ₹ crores) | (0.1877) | 5.2635 | 0.5477 |
Net Cash (Used in)/Generated from Financing Activities (in ₹ crores) | 0.1538 | 5.3278 | 6.9292 |
Cash and Cash Equivalents (in ₹ crores) | 0.0665 | 0.1237 | 0.0005 |
How to Check Allotment Status of Chemkart India Ltd?
1. Visit the Registrar’s Website
Visit the official website of Bigshare Services Pvt Ltd and choose ‘IPO Allotment Status’ from ‘Solutions’. Click on any one of the servers, choose the company name from the dropdown and input either your application number, beneficiary ID or PAN number. Enter captcha and click on ‘Search’ to know the allotment status.
2. Check on the Bombay Stock Exchange Website
The Bombay Stock Exchange (BSE) also has an IPO allotment status page. Go to www.bseindia.com and find the 'Investor Services' tab. Under 'Investors Services', click on 'Status of Issue Application'. This will take you to the IPO allotment status page. On the BSE IPO page, follow these steps:
- Choose the Issue Type
- Select the Issue Name from dropdown
- Put in either your application number or PAN number
- Check the box ‘I’m not a robot’
- Click on ‘Search’ to know allotment status
3. How to Apply for Chemkart India Ltd IPO?
- Log in to your Kotak Securities Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
- Specify IPO details - Enter the number of lots and the price you wish to apply for.
- Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
- Mandate Notification - Your UPI app will receive a mandate notification to block funds.
- Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Chemkart India IPO FAQs
What is the minimum lot size required for Chemkart India IPO?
The minimum lot size is 1200 shares and the investment required is ₹297600.
What is the price band of the Chemkart India IPO?
The price band of Chemkart India IPO is ₹236 to ₹248.
What is the Chemkart India Ltd IPO?
The Chemkart India Ltd IPO comprises a fresh issue and an offer for sale of up to 26,00,000 and 6,30,000 equity shares, respectively.
When will the IPO of Chemkart India Ltd go live?
The exact dates of the IPO are not yet announced.
Who is the chairman and MD of Chemkart India Ltd?
Ankit Shailesh Mehta is the chairman and MD of Chemkart India Ltd.
From where can I read more about Chemkart India Ltd and its IPO?
You can read more about Chemkart India Ltd and its IPO from the company’s draft red herring prospectus here.
